Sector: Healthcare
findl.com provides a comprehensive suite of standardized financial statement data and an assortment of calculated metrics sourced directly from SEC filings, and meticulously cleansed and verified, ensuring reliability. To get the complete financial statement history in quarterly and annual resolution for HOLX, sign up here.
Income Statement
Revenue
$4.0bn
Gross Profit
$2.0bn
Earning before Tax
$628.3m
Net Income
$515.1m
Net Income Common Shareholders
$515.1m
EPS
2.12
Balance Sheet
Cash
$1.9bn
Debt
$2.6bn
Assets
$8.5bn
Liabilities
$3.8bn
Equity
$4.7bn
Enterprise Value
$17.3bn
Cash Flow Statement
Net Cash from Operations
$1.0bn
Net Cash from Investing
$-0.2bn
Net Cash from Financing
$-1.3bn
Net Cash Flow
$-0.5bn
Free Cash Flow
$858.7m
Free Cash Flow per Share
$3.60
Metrics
Price to Equity
33.29
Price to Equity (Damodaran)
33.70
Price to Book
3.69
Net Margin
0.13
Return on Equity
0.10
Return on Sales
0.19
Get immediate access to 5-years of reference grade data for HOLX for free.
Sign upHologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women''s health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
Company Info
Industry
Medical Instruments & Supplies
Employees
6,990
Address
250 Campus Drive
Marlborough, MA 01752
United States
Phone
508 263 2900
Website
Last Updated
2024-02-08
Available Data
Standardized Financial Statements
EOD Price History
Corporate Actions
Institutional Holdings
Insider Transactions
Copyright © findl 2024. All rights reserved.